Characterization of snRNA-related neurodevelopmental disorders through the Spanish Undiagnosed Rare Disease Programs
Sevilla-Porras, M.; Nieto-Molina, E.; Medina, Z.; Damian, A.; Tejedor, J. R.; Ruiz-Arenas, C.; Cazalla, M.; Carmona, R.; Amigo, J.; Goicoechea, I.; Tonda, R.; Bullich, G.; Beltran, S.; Toro-Barrios, N.; Aquino, V.; Soengas-Gonda, E.; Navarro-Moreno, C.; Mena, M.; Corcuera, J.; Martos-Gago, V.; Alvarez-Barona, M.; Barreda-Sanchez, M.; Silvan, C.; Tenorio-Castano, J.; Alves, C.; Alvarez-Mora, M. I.; Rodriguez-Revenga, L.; Madrigal, I.; Ballesta-Martinez, M. J.; Lopez-Gonzalez, V.; Perez, B.; Morales-Conejo, M.; Valenzuela, I.; Codina-Sola, M.; Alemany-Albert, M.; Ballesteros-Cogollos, V.; Rodrig
Show abstract
Programs for Undiagnosed Rare Diseases (URD) with anonymized data sharing are contributing to the earlier genetic diagnosis of patients and to the identification and characterization of novel genetic disorders. Recently, de novo pathogenic variants in two non-coding spliceosomal small nuclear RNAs (snRNAs), RNU4-2 and RNU2-2, key regulators of gene expression during neurodevelopment, have been linked to neurodevelopmental disorders (NDD). With the aim to identify individuals with causal genetic variants in known and novel snRNA genes, we analyzed WGS and clinical data of 1,708 probands with undiagnosed NDD enrolled in the Spanish URD Programs. Selected individuals underwent in-depth re-phenotyping including facial mask analyses (Face2Gene), and blood-DNA methylation profiling was obtained (Infinium methylation Epicv2 microarrays). We identified 38 patients (2.22%) with de novo pathogenic variants in snRNA genes, 28 in RNU4-2 (1.64%), 6 in RNU2-2 (0.35%), and 4 in RNU5B-1 (0,23%). A clinically recognizable NDD (ReNU syndrome) is caused by RNU4-2 variants, with dysmorphic features making a disease-associated facial mask, RNU2-2 associates an early onset epileptic encephalopathy, and RNU5-B1 a less defined NDD with overlapping features. A DNA methylomic episignature was also identified for RNU4-2, which does not overlap with the other conditions. We have also defined autosomal recessive inheritance in 8 additional patients (0.47%) with NDD and biallelic variants in three snRNA genes (3 in RNU4-2, 3 in RNU2-2, and 2 in RNU4-1). Our study has facilitated the quick diagnosis, management, and genetic counselling of 2.69% previously undiagnosed patients with NDD, further reinforcing the value and utility of the URD Programs. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=145 SRC="FIGDIR/small/25335449v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@a353edorg.highwire.dtl.DTLVardef@daf109org.highwire.dtl.DTLVardef@693a5org.highwire.dtl.DTLVardef@1c74402_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Transcriptome-wide outlier approach identifies individuals with minor spliceopathies 96%
- Non-coding variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms 96%
- Loss-of-function of the Zinc Finger Homeobox 4 ( ZFHX4 ) gene underlies a neurodevelopmental disorder 96%
Similar papers in this journal
- Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption 99%
- Systematic analysis of snRNA genes reveals frequent RNU2-2 variants in dominant and recessive developmental and epileptic encephalopathies 95%
- Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder 94%
Similar papers in this journal
- Comprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses 96%
- Biallelic truncation variants in ATP9A are associated with a novel autosomal recessive neurodevelopmental disorder 94%
- Association between genes regulating neural pathways for quantitative traits of speech and language disorders 94%
Similar papers in this journal
- Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature 95%
- Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation 95%
- Regionally enriched rare deleterious exonic variants in the UK and Ireland 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.